Steve Harvey is the Worldwide Leader for Technology and Analytics across IBM’s Business Process Outsourcing unit.  In this role, he is responsible for the operations, go-to-market, offering, sales and infusion of technology and analytics across the global business.  This ranges from running core development and maintenance of applications to the IT delivery, hosting and network infrastructure across the enterprise.

In addition, Steve is leading the emerging business opportunity around the IBM Watson Genomics solution.  IBM and the New York Genome Center plan to initially evaluate Watson’s ability to help oncologists develop more personalized care to patients with glioblastoma, an aggressive and malignant brain cancer that kills more than 13,000 people in the U.S. each year.  The new cloud-based Watson system will be designed to analyze genetic data along with comprehensive biomedical literature and drug databases. The goal of the collaboration is to increase the number of cancer patients who have access to care options tailored to their disease’s DNA.

Previously, Steve led IBM’s Business Analytics and Optimization practice within the Distribution Sector. In that role, Steve was fully responsible for all of IBM’s Business Analytics and Optimization consulting services across the Life Sciences, Consumer Packaged Goods, Retail and Travel & Transportation industries. These services primarily consisted of strategy, advanced analytics (predictive modeling, optimization and simulation), business intelligence, enterprise information management and enterprise content management.

Throughout his career, Steve has led numerous consulting groups and engagements as well as provided client business advisory services across a wide range of fields ranging from CRM to custom software development to internet web technologies.  He is experienced in running large organizations and driving transformation across enterprise clients.


Get every new post delivered to your Inbox

Join other followers:

The postings on this site are my own and do not necessarily represent IBM positions, strategies or opinions.